William T. Atchley
Researcher
University of Arkansas for Medical Sciences
faculty
Research Areas
Is this your profile? Verify and claim your profile
Biography and Research Information
OverviewAI-generated summary
William T. Atchley's research investigates various aspects of respiratory and critical care medicine. His recent publications address topics such as immune checkpoint inhibitor-related pneumonitis in lung cancer patients, the association of tocilizumab with fungal infections in critically ill COVID-19 patients, and the interrelationships between aging and chronic obstructive pulmonary disease (COPD). Atchley has also explored pulmonary hypertension in the context of COPD and interstitial lung disease, including responses to inhaled nitric oxide. His work involves collaborations with multiple faculty members at the University of Arkansas for Medical Sciences, including Nikhil Meena, Rajani Jagana, Sarenthia M. Epps, and Barrett J. Burger, with whom he has co-authored three publications each. Atchley has published 16 total publications, achieving an h-index of 7 with 423 citations.
Metrics
- h-index: 7
- Publications: 16
- Citations: 423
Selected Publications
- Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care (2024) DOI
- Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO) (2024) DOI
- Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions (2023) DOI
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023) DOI
- Ageing and chronic obstructive pulmonary disease: interrelationships (2023) DOI
- Response (2022) DOI
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021) DOI
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021) DOI
- Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer (2021) DOI
Grants & Funding
Collaborators
Researchers in the database who share publications
Similar Researchers
Based on overlapping research topics